We recently demonstrated that co-administration of mouse zona pellucida 3 (mZP3) DNA and protein vaccine enhanced the contraception of mice by increasing humoral immune responses. In this study, we try to use granulocyte-macrophage colonystimulating factor (GM-CSF) to further improve the humoral immune responses induced by mZP3 DNA and protein co-administration. BALB/c mice were intranasally pre-injected with GM-CSF 4 days before co-administration. Compared to DNA and protein coadministration without GM-CSF, the combination of GM-CSF and coadministration significantly enhances humoral immune responses, especially the level of secretory immunoglobulin A (sIgA) in vaginal washes. The enhanced antibody responses are correlated with the upregulated level of interleukin 4 (IL-4) and enhanced maturation of dendritic cells (DCs). Thus, GM-CSF is a potential candidate adjuvant to be used for the development of a safe and effective contraceptive vaccine.
Introduction
Many efforts were focused on the development of a safe and effective contraceptive vaccine for pest animals or human beings. The zona pellucida (ZP) is composed of 3 sulfated glycoproteins (ZP1, ZP2, and ZP3) that have been proposed as candidates for developing contraceptive vaccines, [1] [2] [3] [4] especially ZP3 served as the primary ligand for sperm binding. However, inflammatory T cells induced by ZP vaccinations against ovary always accompanies with the deterioration of ovarian functions. [5] [6] [7] [8] [9] Different approaches were used to develop a vaccine that could avoid cellular responses without impairing humoral responses. [10] [11] [12] [13] [14] Most recently, we demonstrated that mouse ZP3 (mZP3) DNA and protein coadministration enhanced the contraception without abnormal follicular development, which is correlated with high antibody (Ab) titers. 15, 16 Here, we try to use granulocyte-macrophage colonystimulating factor (GM-CSF) to further enhance the humoral immune responses induced by mZP3 DNA and protein coadministration. granulocyte-macrophage CSF is a safe adjuvant and promotes the activation and recruitment of macrophages and dendritic cells (DCs) to the reaction site, which enhances antigen presentation to improve the immunity of different vaccines. [17] [18] [19] [20] [21] Previous study showed that the timing of GM-CSF expression plasmid administration is critical for the induction of T-helper type (Th1/Th2) response. 22 In order to induce high level of Ab responses and avoid Th1 response, GM-CSF plasmid was predelivered 4 days prior to mZP3 DNA and protein coadministration in this study. Since the intranasal coadministration with mZP3 DNA and protein induced both systemic immunoglobulin G (IgG) and mucosal IgA responses, 16 the intranasal route was chosen to deliver antigens. To enhance the efficiency of mucosal delivery, a mucolytic agent lysophosphatidylcholine (LPC) and chitosan (as delivery vehicle) were used for mZP3 DNA and protein vaccines. 16, [23] [24] [25] We demonstrated that the combination of GM-CSF and coadministration enhanced both systemic and mucosal humoral immune responses and inhibited cellular immune responses.
Materials and Methods

Recombinant Plasmid Construction and Expression in Vivo
The pcDNA3-mZP3 (pcD-mZP3) and pGEX-4T-1-mZP3 plasmids were constructed according to previous description. 15, 16 The pcD-mZP3 was digested by restriction enzymes EcoRI and XhoI (TaKaRa, Japan) and mZP3 gene fragments were purified, then subcloned into pVAX1 vector, and designed as p-mZP3. Mouse GM-CSF sequence (coding region of nucleic acids: 1-399; GenBank No.NM_009969) was amplified by reverse transcription-polymerase chain reaction (RT-PCR) from total RNA isolated from the spleen of BALB/c mice using a TRIzol RNA Isolation Kit (Invitrogen, Grand Island, New York). The GM-CSF gene fragments were constructed into pVAX1 vector at EcoRI and BamHI sites by digestions and named as p-GM-CSF.
The expression levels of p-GM-CSF and p-mZP3 were tested by hydrodynamic injection technique. 26 Briefly, 25 mg (10 mg/mL) of plasmid was intravenously administered into mouse within 10 seconds with a 21-gauge needle; pVAX1 was used as a negative control. Total RNA was extracted from the liver 7 hours after the injection and the expressions of GM-CSF and mZP3 genes were detected by RT-PCR. RNAs from livers of mice injected with p-GM-CSF or p-mZP3 were used as the templates for PCR to exclude the contamination of DNA. p-GM-CSF and p-mZP3 as the templates for PCR were used as positive controls. The primers used for GM-CSF are sense, 5 0 -CGGGATCCAGGATGTGGCTGCAGAATTTACTT-3 0 ; antisense, 5 0 -CGGAATTCTCA AAGGGGATATCAGTCA-GAA-3 0 ; the expected fragment is 400 bp. The primers used for mZP3 are sense, 5 0 -GTTGCCTTGTGGATGGTC-3 0 ; antisense, 5 0 -GGTGATGTAGA GCGTATTGC-3 0 ; the expected fragment is 130 bp.
Immunization of Mice and Sample Collection
The mZP3 protein were purified as described previously. 15 The vaccine formulations were prepared by complexing chitosan (Dalian Xindie Chitin Co, Ltd, Dalian, China) with the plasmid DNA or protein according to the previous formula description. 16 These complexes were designated as Chi-pVAX, Chi-p-GM-CSF, and Chi-(p-mZP3 þ mZP3), respectively.
Adult female BALB/c mice, 6 to 8 weeks old, purchased from Center for Disease Control and Prevention (Xinjiang, China), were housed under controlled temperature and humidity conditions. All experiments were conducted in compliance with the guidelines of the Chinese Animal Care for Laboratory Animals. All mice were randomly divided into 4 groups (n ¼ 10). Each mouse was pretreated with 10 mL of 0.1% LPC for 1 hour prior to vaccine administration. Mice were intranasally preinjected with Chi-p-GM-CSF 4 days before Chi-(p-mZP3 þ mZP3) coadministration as the experimental group. Mice intranasally administered with Chi-pVAX, Chip-GM-CSF, and Chi-(p-mZP3 þ mZP3) served as the control group ( Figure 1 ). Each mouse received DNA or protein vaccines at 100 mg, respectively, by holding them in an inverted position and pipetted 40 mL encapsulated mixes into nasal cavity and allowed to inhale on day 0 and boosted at 2-week interval for 3 times.
Serum samples were collected from mice prior to each administration. Vaginal wash samples were collected by washing the vaginal cavities of mice with 150 mL of sterile phosphate-buffered sodium (PBS), and all samples were stored at À20 C. 
Assay of Antibodies
The mZP3-specific immunoglobulin G (IgG, IgG1, and IgG2a) and secretory immunoglobulin A (sIgA) in serum and vaginal washes were determined by enzyme-linked immunosorbent assay (ELISA), respectively, according to previous description with some revision. 16 
T-Cell Proliferation
Single lymphocyte suspensions were prepared from spleens of the mice on 7 days after the final administration as described previously. 16 The splenocytes were cultured in 96-well plate at 3 Â 10 6 cell/well and stimulated with 10 mg/mL mZP3 in vitro for 48 hours and then 20 mL of 5 mg/mL 3-(4, 5dimethylthiazol-2-yi)-2, 5-diphenyltetrazolium (MTT, Sigma) solution was added. The plate was read at 490 nm by a spectrophotometer (Benchmark, Bio-Rad). Data were expressed as stimulation index (SI), calculated as the mean reading of triplicate wells stimulated with an antigen, and divided by the mean reading of triplicate wells stimulated with the medium. Each group included at least 3 mice. Experiments were carried out 2 or 3 times.
Flow Cytometric Analysis
The following fluorescently labeled anti-mouse monoclonal antibodies (mAbs) were used in this study: anti-interferon (IFN)-g-phycoerythrin (PE), anti-interleukin (IL)-4-PE, antimajor histocompatibility complex (MHC)-II-PE, anti-CD4fluoroscein isothiocyanate (FITC), anti-CD11c-FITC, isotype controls, monensin, and Fc-Block were purchased from BD PharMingen (BD Bioscience, California). T-cells were isolated from mice 7 days after the final immunization and stimulated with mZP3 protein (10 mg/mL) for 5 hours, followed by the addition of the monensin at 2 mg/mL for 8 hours and then blocked with 1 mL of Fc-Block (0.5 mg/mL) for 30 minutes at 4 C. Cell surface staining was performed using CD4-FITC before fixing with 4% paraformaldehyde and the cell membranes were ruptured with 0.1% saponin. The cells were intracellularly stained with IL-4-PE or IFN-g-PE for 30 minutes at 4 C and analyzed with a FACSCalibur using the Cell Quest Pro Software (BD Bioscience).
For DCs staining, the splenocytes were isolated from spleen of mice on day 5 after the final immunization. Cell surface staining was performed using CD11c-FITC combined with MHC-II-PE.
Statistical Analysis
The experiment data were analyzed using student t test and 1-way analysis of variance (ANOVA) using GraphPad prism 4 software. A value of P < .05 was considered to be statistically significant.
Results
Expression of Recombinant Plasmids in Vivo
To test whether p-GM-CSF and p-mZP3 can be properly expressed in mice, plasmids were injected into mice by hydrodynamic method. The total RNA was extracted from liver 7 hours after the injection and the expressions of GM-CSF and mZP3 genes were detected by RT-PCR. Results showed that the specific bands for GM-CSF (400 bp) and mZP3 (130 bp) were obtained using complementary DNA (cDNA) from liver of mice injected with p-GM-CSF and p-mZP3, respectively, but not from the liver of mice injected with pVAX1 vector (Figure 2) . The results revealed that GM-CSF and mZP3 genes were correctly expressed in the eukaryotic system.
Effect of GM-CSF on Humoral Immune Responses
It has been demonstrated that high level of ZP3-specific antibodies (Abs) correlated with the infertility. 8, 15, 16, 27 Enzymelinked immunosorbent assay (ELISA) was used to evaluate the effect of GM-CSF on Ab responses induced by p-mZP3 þ mZP3 coadministration. The mZP3-specific IgG in Chi-(p-mZP3 þ mZP3) coadministered group was induced after first injection and boosted by the following immunization. The level was significantly higher than Chi-p-GM-CSF and Chi-pVAX groups and reached the highest 2 weeks after third immunization ( Figure 3A) . The combination of Chi-p-GM-CSF and Chi-(p-mZP3 þ mZP3) further enhanced Ab responses compared to Chi-(p-mZP3 þ mZP3) coadministered group ( Figure 3A) . The Ab responses lasted at least 5 weeks after final immunization. The results showed that GM-CSF could enhance humoral immune responses induced by p-mZP3 þ mZP3 coadministration.
The subtype of IgG was further analyzed by ELISA. Chi-(p-mZP3 þ mZP3) coadministration elicited both IgG1 and IgG2a, but the level of IgG1 was much higher than IgG2a. The combination of Chi-p-GM-CSF and Chi-(p-mZP3 þ mZP3) further enhanced IgG1 response induced by Chi-(p-mZP3 þ mZP3) coadministration but not for IgG2a ( Figure 3B ). The result suggested that preinjection of GM-CSF triggered Th2-biased immune response that is potentially advantageous for humoral immunity.
Effect of GM-CSF on Mucosal Immune Responses
To investigate the adjuvant effect of GM-CSF on the mucosal immune responses, sIgA Ab in vaginal washes was analyzed by ELISA. The sIgA level in the combination of Chi-p-GM-CSF and Chi-(p-mZP3 þ mZP3) group was significantly higher than other groups at all time points after first immunization (Figure 4) . The results showed that GM-CSF enhanced both systemic and mucosal Ab responses induced by mZP3 DNA and protein coadministration.
Cellular Immune Responses
To detect mZP3-specific lymphocyte proliferative responses, splenocytes were isolated from mice 7 days after the final administration and stimulated with mZP3 protein for 48 hours. The mZP3-specific T-cell proliferation was observed in the Chi-(p-mZP3 þ mZP3) coadministered group but not in Chip-GM-CSF þ Chi-(p-mZP3 þ mZP3) coadministered group that was similar with other 2 control groups ( Figure 5 ). The results indicated that preinjected GM-CSF inhibited T-cell response induced by p-mZP3 þ mZP3 coadministration.
Effect of GM-CSF on Cytokine Production
Antibody analysis showed that preinjected GM-CSF triggered Th2-biased immune responses. To further prove it, the cytokine profiles, such as IFN-g and IL-4, indicators of Th1-and Figure 5 . T-cell proliferation in immunized mice. T cells were isolated from mice on day 7 after the final administration and restimulated in vitro with mZP3 protein as a specific antigen and the proliferation activity was determined by the MTT method. Data were expressed as stimulation index. There was a significant difference (*P < .05) among Chi-(p-mZP3 þ mZP3) and other groups. MTT indicates 3-(4, 5-dimethylthiazol-2-yi)-2, 5-diphenyltetrazolium; mZP3, mouse zona pellucida 3.
Th2-like immune response, were detected on day 7 after the final immunization. Percentage of IL-4 in CD4 þ T-cells generated by Chi-p-GM-CSF þ Chi-(p-mZP3 þ mZP3) coadministered group is higher than the other groups ( Figure 6A) . However, the level of IFN-g in Chi-p-GM-CSF þ Chi-(p-mZP3 þ mZP3) group is lower than Chi-(p-mZP3 þ mZP3) group ( Figure 6B ), although they did not reach the statistical significance. The results were consistent with the Ab analysis and T-cell proliferative responses, suggesting that preinjected GM-CSF triggered Th2-biased responses.
Effect of GM-CSF on DC Maturation
The GM-CSF is a pleiotropic cytokine that can enhance the recruitment of monocytes/macrophages and DCs to inflammatory sites and the activation of antigen-presenting cells (APCs) including upregulation of MHC and CD80/CD86 molecules. 19, 28 To investigate whether preinjection of GM-CSF can affect the maturation of DCs, splenocytes were isolated on day 5 after final immunization and the maturation of DCs was analyzed by flow cytometric analysis. The levels of MHC-II expression in CD11c þ cells from mice immunized with Chip-GM-CSF þ Chi-(p-mZP3 þ mZP3) or Chi-(p-mZP3 þ mZP3) were significantly higher than Chi-pVAX and Chip-GM-CSF groups (Figure 7) . The combination of Chip-GM-CSF and Chi-(p-mZP3 þ mZP3) increased the level of MHC-II expression compared with Chi-(p-mZP3 þ mZP3) coadministered group, although they did not reach statistical significance (Figure 7) . The levels of CD86 expression in all groups were similar (data not shown). The results suggested that GM-CSF, to some extent, enhanced the maturation of DCs to promote the presentation of mZP3 antigen and improve the humoral immune responses.
Discussion
Recently, we developed a safe and effective contraceptive vaccine using coadministration of mZP3 DNA and protein-based vaccines and the contraception was correlated with high Ab titers. 15, 16 In this study, we have shown that GM-CSF further enhanced the systemic and mucosal Ab responses induced by mZP3 DNA and protein coadministration. The enhanced humoral responses might be due to the upregulated level of IL-4 and enhanced maturation of DCs. We have also shown that GM-CSF mainly enhanced Th2biased responses.
Granulocyte-macrophage CSF as an adjuvant promotes the activation and recruitment of APCs to reaction site to enhance antigen presentation and improve the immunity of different vaccines. [17] [18] [19] [20] [21] Kusakabe et al have shown that the timing of GM-CSF administration is critical for the induction of Th1/Th2 response. 22 Considering Ab responses play important roles in contraception, 7, 9, 15, 16, 29 we preadministered GM-CSF 4 days before mZP3 DNA and protein coadministration, and the timing of GM-CSF administration induced Th2-biased responses, which was consistent with previous results. 22 Previous study showed that IgA Ab reactivity in the vaginal tract played a pivotal role in the decrease of pups. 30 Both Chi-(p-mZP3 þ mZP3) and Chi-p-GM-CSF þ Chi-(p-mZP3 þ mZP3) administration in mice not only induced high levels of systemic IgG Ab but also produced high levels of local sIgA Ab, but the level of the latter is higher than the former. Granulocyte-macrophage CSF enhanced both systemic and local Ab responses that might cause lower fertility based on the results of our previous studies. 15, 16 ZP3 contained T-cell epitopes and could induce inflammatory T-cell responses that were correlated with the deterioration of ovarian functions. 7, 9, 15, 16, 31 Our previous studies showed that coadministration of mZP3 DNA and protein induced humoral and Th2-biased responses, whereas Th1 responses were inhibited. 15, 16 This strategy caused lower fertility without inflammatory T-cell infiltration into ovary. Here, we showed GM-CSF enhanced humoral and Th2 responses induced by mZP3 DNA and protein coadministration but not for Th1 responses through enhancing the maturation of DCs.
In conclusion, our study demonstrated that the systemic and local Ab responses induced by mZP3 DNA and protein coadministration were enhanced by preadministration of GM-SCF. Further, preadministration of GM-SCF generated Th2 responses and inhibited the inflammatory T-cell responses. The results suggested that GM-CSF might be used as an adjuvant to develop a safe and effective immunocontraceptive vaccine. 
